Latest by Myles Helfand

This Week in HIV Research: To Seek and to Treat

This week: the successes of Vancouver's harm reduction and HIV outreach programs; the safety of stem-cell transplantation; how biomarkers predict health events; and how to improve partner notification.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: A Viral Prediction

Our latest jaunt through HIV journals looks at a symptom-based scoring system to predict acute HIV, the effect of a person's sex on psychomotor function, and the value of vitamin D supplementation to moderate lipid levels.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: You Don't Know Jak

Among the research covered this week are fresh findings regarding Jak inhibitors, an exciting experimental class of HIV medications.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Looking Forward, Looking Back

In our final installment of 2017, we intermingle forward-looking research with some retrospective analysis. We begin our four-study tour by joining researchers in Tennessee for an exercise in HIV outbreak prediction.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Duracell Batteries of Antiretroviral Therapy

Among this week's selection of four studies, we learn about data from a large study exploring the relative durability of first-line antiretroviral regimens stratified by drug class. (Spoiler alert: Older protease inhibitors don't do so well.)

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: In the Care Continuum, Self-Worth Matters

Among this week's brief tour of recently published studies, we get a reminder about just how deeply mental health can affect an HIV-positive person's clinical care.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Repeat Diagnoses Reveal Gaps in Care

Sobering data regarding linkage to HIV care among women in the U.S.; Latinx HIV incidence inequalities; efficacy of hepatitis C treatment among people with HIV; and a call for frequent STI testing among at-risk people with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Quality of Life Is About More Than Viral Suppression

This week, we get an important reminder that an HIV-positive person's sense of wellbeing doesn't start and end with an undetectable viral load.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Test-and-Treat Ain't Just for HIV

A quick look at how the test-and-treat approach so widely employed in HIV can be of value in addressing hepatitis C coinfection as well; the latest data regarding a late-stage fixed-dose combination drug; a dramatically falling HIV incidence rate amo...

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Is HIV or Diabetes More Hurtful to the Heart?

This week, among other notable stories, we gain a new perspective on the relative risk of cardiovascular disease for people with HIV compared to people with diabetes.

By Barbara Jungwirth and Myles Helfand